Home›Stock Screener›Concord Drugs›P/E Ratio

Concord Drugs P/E Ratio

Current P/E Ratio
96.19
High Valuation
Very High - High growth expectations or significantly overvalued

Concord Drugs (CONCORD) P/E ratio is 96.19 (High), EPS (TTM) ₹0.95, current price ₹77.45 on BSE vs historical average P/E of 97.64 (50.0th percentile) — Very High - High growth expectations or significantly overvalued. Read CONCORD dividend history for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 96.19
Current Price ₹77.45
EPS (TTM) ₹0.95
Exchange BSE

Valuation Signal

Signal Overvalued
Historical Avg 97.64
Historical Range 33.56 - 161.73
Percentile 50.0%

Sector Context

Sector Average 54.59
Sector Median 31.04
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹0.82
Mar 2026 ₹0.47
Sept 2025 ₹0.19

CONCORD P/E Ratio — Valuation Signal & Historical Context

Concord Drugs P/E 96.19 vs historical average 97.64, range 33.56–161.73 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Concord Drugs share price screener.

  • Stock appears overvalued with PE of 96.19, suggesting caution for new investments
  • Trading at premium to sector average PE of 54.59

Concord Drugs P/E Ratio Historical Trend

CONCORD annual price-to-earnings ratio — 2 years, EPS and year-end price. Current P/E 96.19 vs historical average 97.64. See CONCORD book value to compare market price against book value per share.

CONCORD Historical P/E Ratio — EPS, Year-End Price & Valuation

Concord Drugs annual P/E ratio, EPS (₹), year-end price and valuation category on BSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 161.73 0.51 ₹82.48 BSE High
2022 33.56 0.97 ₹32.55 BSE High

CONCORD vs Healthcare Peers — P/E Ratio Comparison

Concord Drugs P/E 96.19 vs Healthcare average 54.59, median 31.04 — range 2.86–950.0.

Sector Average
54.59
Sector Median
31.04
Lowest P/E
2.86
Highest P/E
950.0
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Sunrest Lifescience SUNREST 3.65 ₹29 Low
Phaarmasia PHRMASI 3.89 ₹69 Low
JFL Life Sciences JFLLIFE 4.64 ₹59 Low
Sun Pharma Advanced Rese… SPARC 4.69 ₹7,502 Low
Shelter Pharma SHELTER 5.32 ₹50 Low
Mono Pharmacare MONOPHARMA 6.02 ₹19 Low
Royal Sense ROYAL 7.4 ₹51 Low
Zenith Drugs ZENITHDRUG 7.69 ₹79 Low
Amwill Health Care AMWILL 7.71 ₹88 Low